Fractyl Health (GUTS)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from GUTS's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Results from SEC filings
Fiscal years, from Fractyl Health's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $120,000 | $93,000 | $0 |
| Net income | -$77M | -$69M | -$141M |
| Free cash flow | -$43M | -$67M | -$91M |
| EPS (diluted) | -$45.29 | -$1.62 | -$1.86 |
| Operating margin | -42363.3% | -100571.0% | — |
Superinvestors who own GUTS
From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Lee Ainslie Maverick Capital |
Held | $3M | 0.03% | Q2 2026 |
Insider buying
Open-market purchases by Fractyl Health's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Sep 14, 2026 | William Bradley Director |
64,516 | $0.62 | $39,903 |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when GUTS trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Fractyl Health insiders buying the stock?
1 open-market insider purchase of GUTS in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Fractyl Health?
1 of the superinvestors Investingly tracks hold GUTS in their latest 13F, including Lee Ainslie.
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.